CClinicalTrials.gg
Not yet recruitingNCT07669688Updated Jul 7, 2026

Pulse Wave Transit Time After Infraclavicular Block

An observational study in Infraclavicular Brachial Plexus Block, sponsored by Sakarya University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Sakarya University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
25
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This prospective observational study aims to evaluate the time-dependent changes in Pulse Wave Transit Time (PWTT) following ultrasound-guided infraclavicular brachial plexus block. PWTT is a non-invasive hemodynamic parameter reflecting vascular tone and sympathetic nervous system activity. Patients undergoing upper extremity surgery under infraclavicular block will be monitored using standard perioperative monitoring devices. PWTT measurements will be obtained before and after block placement at predefined time intervals. Secondary outcomes will include perfusion index, skin temperature, heart rate, blood pressure, respiratory rate, and oxygen saturation. The study seeks to determine whether PWTT can serve as an objective and non-invasive marker of sympathetic blockade following infraclavicular block.

Read the detailed description

Regional anesthesia success is traditionally assessed using sensory and motor block evaluation methods that rely on patient cooperation and subjective responses to external stimuli. However, these methods may be difficult to apply in sedated, uncooperative, or communication-impaired patients. Therefore, objective and non-invasive indicators of sympathetic blockade have gained increasing interest in regional anesthesia practice.

Pulse Wave Transit Time (PWTT) is defined as the time interval between the R-wave on the electrocardiogram and the arrival of the corresponding pulse wave detected by a peripheral pulse oximeter. PWTT reflects vascular tone, arterial compliance, and hemodynamic status. Sympathetic blockade induced by peripheral nerve blocks results in vasodilation and reduced vascular resistance, potentially leading to measurable changes in PWTT. Previous studies have demonstrated the utility of objective parameters such as perfusion index, skin temperature, blood flow measurements, and PWTT in assessing block success. However, data regarding the temporal changes of PWTT following infraclavicular brachial plexus block remain limited.

The primary objective of this prospective observational study is to investigate the time-dependent changes in PWTT after ultrasound-guided infraclavicular brachial plexus block. The study will be conducted in patients undergoing upper extremity surgery under infraclavicular block at Sakarya Training and Research Hospital.

Patients scheduled to receive infraclavicular block as part of their routine clinical care will be enrolled after providing informed consent. The block procedure is not performed for research purposes and represents standard clinical practice. Following block administration, PWTT values will be recorded from the blocked extremity using standard monitoring equipment. Measurements will be obtained before block placement and at 0, 5, 10, 15, and 20 minutes after block completion. Baseline PWTT measurements will also be obtained from the contralateral upper extremity.

Secondary outcome measures will include perfusion index, skin temperature of both upper extremities, heart rate, non-invasive blood pressure, respiratory rate, and oxygen saturation. Demographic and clinical data will also be recorded.

All measurements will be collected according to a predefined protocol using standardized monitoring equipment. Since PWTT is an objective device-derived parameter, observer dependency is expected to be minimal. Data collection personnel will be separated from the clinician performing the block whenever feasible to reduce measurement bias. All collected data will be anonymized prior to statistical analysis.

This study is designed as a single-center, prospective observational investigation without randomization or intervention beyond routine clinical care. The findings may contribute to the development of PWTT as a practical, objective, and non-invasive marker of sympathetic blockade following infraclavicular brachial plexus block.

02

Conditions studied

  • Infraclavicular Brachial Plexus Block

Keywords

  • Infraclavicular Block
  • Pulse Wave Transit Time
  • Regional Anesthesia
  • Brachial Plexus Block
  • Sympathetic Blockade
03

In context

Lead sponsor

Sakarya University is the lead sponsor of 178 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will consist of adult patients aged 18-65 years with ASA physical status I who are scheduled to undergo elective upper extremity hand surgery under ultrasound-guided infraclavicular brachial plexus block. All participants will receive standard-of-care anesthesia management. Patients with contraindications to peripheral nerve block, significant systemic disease, obesity (BMI ≥30 kg/m²), coagulation disorders, opioid use, or conditions affecting sympathetic activity will be excluded. Only patients who provide informed consent will be enrolled.

Inclusion criteria

  • Patients undergoing elective upper extremity hand surgery
  • 18 - 65 years
  • ASA I
  • No coagulopathy, thrombocytopenia, coagulation disorders
  • Patients who provide informed consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • History of drug allergy relevant to study procedures or local anesthetics
  • Body mass index (BMI) ≥ 30 kg/m²
  • Body weight \< 40 kg
  • Age \< 18 years or > 65 years
  • History of significant cardiac disease (e.g., arrhythmia, conduction abnormalities)
  • Coagulopathy (INR > 1.5 or platelet count \< 100,000/mm³)
  • Pregnancy or lactation
  • Infection at the site of peripheral nerve block
  • ASA II-IV
  • Failed block or motor block duration exceeding 30 minutes
  • Patients reporting pain (NRS ≥ 3), due to potential influence on sympathetic activity
  • Chronic opioid use
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
25 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Infraclavicular Block Group

    Patients undergoing routine ultrasound-guided infraclavicular brachial plexus block for upper extremity surgery will be included in this observational cohort. Pulse Wave Transit Time (PWTT) and other hemodynamic parameters will be measured at predefined time points before and after block administration. No additional intervention beyond standard clinical care will be performed for research purposes.

    Procedure: Ultrasound-guided infraclavicular brachial plexus block

Interventions

  • ProcedureUltrasound-guided infraclavicular brachial plexus block

    Ultrasound-guided infraclavicular brachial plexus block will be performed as part of routine clinical anesthesia practice for upper extremity surgery. Local anesthetic will be administered according to standard institutional protocols. No additional or experimental drug or procedure will be applied for research purposes. Pulse Wave Transit Time (PWTT) and other hemodynamic parameters will be recorded before and after block placement at predefined time intervals.

06

What researchers measure

Primary outcomes

  1. Change in Pulse Wave Transit Time

    The primary outcome is the time-dependent change in Pulse Wave Transit Time (PWTT) following ultrasound-guided infraclavicular brachial plexus block. PWTT will be measured as the interval between the R-wave of the electrocardiogram (ECG) and the corresponding pulse wave detected by peripheral pulse oximetry. Measurements will be recorded at baseline (pre-block) and at 0, 5, 10, 15, and 20 minutes after block placement. The primary analysis will evaluate the change in PWTT over time within the blocked extremity.

    Time frame: 20 minutes after infraclavicular block

Secondary outcomes

  1. Perfusion Index

    Changes in perfusion index (PI) measured from the pulse oximeter at the blocked and contralateral upper extremities at baseline and at 0, 5, 10, 15, and 20 minutes after infraclavicular block.

    Time frame: 20 minutes after infraclavicular block

  2. Skin Temperature

    Changes in skin temperature of the blocked and contralateral upper extremities measured at baseline and at 0, 5, 10, 15, and 20 minutes after block placement.

    Time frame: 20 minutes after infraclavicular block

  3. oxygen saturation

    Changes in peripheral oxygen saturation measured using pulse oximetry during the study period.

    Time frame: 20 minutes after infraclavicular block

07

Study locations

1 site
  • Sakarya University-Anesthesiology and Reanimation Department
    Sakarya, Turkey (Türkiye)
08

References and documents

Publications

  • Choi EJ, Lim JA, Choi CH, Kim DH, Jo S, Kim J. Changes in pulse wave transit time variability after interscalene brachial plexus block placement. Korean J Anesthesiol. 2026 Feb;79(1):82-94. doi: 10.4097/kja.24861. Epub 2025 May 21. PubMed 40398868 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07669688
Lead sponsor
Sakarya University
Responsible party
Burçin Alaçam, MD (principal investigator, Sakarya University) — Principal investigator
First posted
Jun 25, 2026
Start date
Jul 20, 2026 (estimated)
Primary completion
Oct 15, 2026 (estimated)
Completion
Nov 15, 2026 (estimated)
Last update
Jul 7, 2026

Study contacts

Burçin Alaçam
Contact
burcin.ersoy90@gmail.com
+905465903851

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion